Are you maximizing the commercial impact of your real-world evidence?

Posted by Tom Hemy on

Over the past few years global pharma and medtech companies have invested heavily in real-world evidence (RWE). RWE is becoming essential as payers and providers increasingly seek evidence to support the effectiveness of a product in the real world.

Personalized and data-driven: the changing nature of pharmaceutical sales

Posted by Tom Hemy on

Customer engagement in the life sciences industry has changed. Not only do key account managers find themselves collaborating with a range of different personnel, but engagements have shifted from traditional ‘one-size-fits-all’ presentations to highly tailored, data-driven, individualized...

Company Updates

Looking for an older blog post?

We recently changed the location of our blog.
Visit the blog archive to find our archived posts.